Two automated volumetric methods were superior in measuring breast density.
Precision measurement for breast density was better with Volpara and Quantra methods than for either Cumulus ABD and CumulusV, according to a study published in the journal Radiology.
Researchers from Canada and the U.S. sought to estimate the reliability of a reference standard two-dimensional area-based method and three automated volumetric breast density measurements using repeated measures.
A total of 30 women undergoing screening mammography between March 2013 and May 2013 participated in the study. The women ranged in age from 42 to 90 (mean age 60). They underwent a repeated left craniocaudal examination performed by a second technologist.
The breast density was measured by using an area-based method (Cumulus ABD) and three automated volumetric methods (CumulusV [University of Toronto], Volpara [version 1.4.5; Volpara Solutions, Wellington, New Zealand), and Quantra [version 2.0; Hologic, Danbury, Conn]),” wrote the authors. “Discrepancy between the first and second breast density measurements (Î1–2) was obtained for each algorithm by subtracting the second measurement from the first. The Î1–2 values of each algorithm were then analyzed with a random-effects model to derive Bland-Altman–type limits of measurement agreement.”
The results showed that the precision was better for Volpara and Quantra than for either Cumulus, which had higher variability.
The researchers concluded that breast density variability was lowest for Volpara and Quantra. “These algorithms may be more suited to incorporation into a risk model,” they wrote.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.